Glyscend Therapeutics Announces Initiation of Phase 1 Clinical Trial on the Heels of Preclinical Data Presented at EASD 2021 on the Metabolic Benefits of its Oral Polymer-based Duodenal Exclusion Therapy
Phase 1 clinical trial currently underway in Australia investigating a noninvasive, oral polymer therapy that dramatically improves glucose homeostasis with...

Democrats Sweep US Midterm Elections, Winning Senate and House as Trump Faces Lame-Duck Presidency
Union Cabinet Approves Two-Year Extension for Agniveer Service Tenure
Kerala Lottery DhanaLekshmi DL-76 results declared for November 4 draw
Kohli’s 74 Seals India’s Auckland Win as DLS Method Decides Series Opener
Sophie Devine Four-For Seals Scorchers Win as Women’s Big Bash League Battles Intensify 


















